title: Severe early acute humoral rejection resulting in allograft loss in a renal transplant recipient with Campath-1H induction therapy.
authors.affiliation: Department of Anatomical Pathology, St Vincent's Hospital, 41 Victoria Parade, Fitzroy 3065, Victoria, Australia. hillpa@svhm.org.au
authors.forename: Prue
authors.initials: P
authors.lastname: Hill
authors.forename: Elena
authors.initials: E
authors.lastname: Gagliardini
authors.forename: Piero
authors.initials: P
authors.lastname: Ruggenenti
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Remuzzi
mesh_terms: D000208:Acute Disease; D000328:Adult; D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006084:Graft Rejection / Q000139:chemically induced*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000601:surgery*; D016030:Kidney Transplantation; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D000074323:Alemtuzumab